Michael Aramini, DPM
Foot & Ankle Surgery · Reno, NVNPI 1083725436
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $56,475 of the $59,756 with a category attached, or 94.5%. Amgen accounts for 99.2% of it on its own, with 14 other manufacturers making up the rest. Among foot & ankle surgery clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $506.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$59K
- Paratek Pharmaceuticals, Inc.$135
- Smith+Nephew$72
- Tactile Systems Technology Inc$51
- Organogenesis Inc.$28
- Treace Medical Concepts, Inc.$28
- plus $190 from 9 others
What the payments were for
- Speaking & faculty fees$56,47595%
- Travel & lodging$1,1462%
- Food & beverage$2,1354%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 93 | $59,252 |
| Paratek Pharmaceuticals, Inc. | 7 | $135 |
| Smith+Nephew | 4 | $72 |
| Tactile Systems Technology Inc | 3 | $51 |
| Organogenesis Inc. | 1 | $28 |
| Treace Medical Concepts, Inc. | 1 | $28 |
| Urgo Medical North America, LLC | 1 | $28 |
| Abbott | 1 | $27 |
| Orthofix Medical, Inc. | 1 | $25 |
| Kerecis Limited | 1 | $23 |
| Medtronic | 1 | $21 |
| Paragon 28, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Nevro Corp. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$57,110
How this compares
$59,756 in reported general payments places this provider in the 90th percentile of 84 foot & ankle surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 110 | $1,769 |
| Duloxetine Hcl | 60 | $1,739 |
| Celecoxib | 19 | $1,419 |
| Allopurinol | 107 | $1,364 |
| MethotrexateMethotrexate Sodium | 33 | $1,149 |
| Gabapentin | 69 | $944 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 72 | $659 |
| Meloxicam | 90 | $528 |
| Colchicine | 17 | $492 |
| Methylprednisolone | 77 | $422 |
| Doxycycline Hyclate | 43 | $422 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 45 | $379 |
| Terbinafine Hcl | 20 | $190 |
| Oxycodone Hcl | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Reno
- Gregory LundeenReno$301K
- Scott WhitlowReno$28K
- Austin HallReno$17K
- Spenser CassinelliReno$11K
- Franklin NebekerReno$5K
- David EllisReno$3K
- Michael KresslerReno$2K
- Jeffrey TucciReno$1K
- Troy WatsonLas Vegas$1.2M
- Roman SibelHenderson$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.